Perigon Pharmacy 360 has been selected to join Genentech’s Limited Distribution Network for HEMLIBRA

Perigon Pharmacy 360 is excited to announce we have been selected to join Genentech’s Limited Distribution Network for HEMLIBRA.

HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. It’s the only subcutaneous injection for hemophilia A with or without inhibitors.

For more information about HEMLIBRA, visit hemlibra.com.